Why Is Drug Pricing Higher In US? Study Takes Aim At R&D Argument
Amgen, Biogen, Pfizer and Teva generated more than twice their global R&D budgets with higher pricing in the US compared to Western Europe and Canada, researchers at Memorial Sloan Kettering found.
You may also be interested in...
Oncologists charge at least 50% more for Lupron and Aranesp than do urologists or nephrologists, researchers with Johns Hopkins and Memorial Sloan Kettering found.
Estimate in JAMA paper is significantly lower than often-cited $2.6bn in research and development costs projected in a 2014 study by Tufts Center for the Study of Drug Development.
Trump tweets about plans for 'new system where there will be competition' to address Rx costs as Republican effort to repeal and replace the Affordable Care Act officially gets underway with release of two House bills.